Curi Wealth Management, LLC Biogen Inc. Transaction History

Curi Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$187.54 - $223.02 $750 - $892	-4 Reduced 3.31%	117 $24,000
Q1 2022 May 06, 2022	BUY	$193.77 - $244.14 $19,377 - $24,414	100 Added 476.19%	121 $25,000
Q4 2021 Feb 09, 2022	BUY	$223.92 - $287.77 $4,702 - $6,043	21 New	21 $5,000
Q1 2021 Apr 29, 2021	SELL	$242.95 - $284.63 $5,101 - $5,977	-21 Closed	0 $0
Q4 2020 Mar 19, 2021	BUY	$236.26 - $355.63 $4,961 - $7,468	21 New	21 $5,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Curi Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Curi Wealth Management, LLC with notifications on news.